Isigaba Sokuqala Ukwelapha Umdlavuza Wamaphaphu 2026: Izinketho Nezindleko ZaseShayina - Izibhedlela Eziseduze Nami 

Isigaba sokuqala sokwelashwa komdlavuza wamaphaphu ngo-2026 sigxile ekungeneleleni ekwelapheni, ikakhulukazi ukuhlinzwa noma i-stereotactic ablative radiotherapy (SABR), evamise ukuthuthukiswa yi-perioperative immunotherapy ezigulini ezifanele. E-China, izibhedlela ezihamba phambili manje zisebenzisa i-AJCC 9th edition system staging futhi zinikeza amasu athuthukile ahlasela kancane, nezindleko zihluka kakhulu phakathi kwezinkampani zikahulumeni nezizimele ngokusekelwe enkingeni yokunakekelwa kanye nezidingo zokuhlola amangqamuzana.

Ukuqonda Izinketho Zokwelashwa Komdlavuza Wesigaba Sokuqala ngo-2026

Isimo se- isigaba esisodwa somdlavuza wamaphaphu iye yavela ngendlela emangalisayo ngo-2026, isuka endleleni yokuhlinzwa yaya esu eliqondene nawe, elenziwa ngezindlela eziningi. Umdlavuza wamaphaphu weseli ongewona omncane (i-NSCLC), ikakhulukazi izigaba I kuye ku-IIIB, manje usubukwa ngelensi yomuthi onembile. Umgomo oyinhloko uhlala ukususwa okuphelele kwesimila, kodwa izindlela zokufeza lokhu kanye nokwelashwa okusekelayo okuzungezile ukuhlinzwa sekuye kwaba yinkimbinkimbi kakhulu.

Imihlahlandlela yamanje igcizelela ukubaluleka kwesiteji esinembile ngaphambi kwanoma yikuphi ukungenelela. Ukwamukelwa kohlelo lwesiteji lwe-AJCC lwe-9th lwe-TNM kuye kwalungisa indlela izimila ezihlukaniswa ngayo, kwaqinisekisa ukuthi iziguli zithola ukwelashwa okufanele kakhulu komthwalo wazo wezifo othize. Lokhu kunemba kubalulekile ngoba ngisho nasesiteji sokuqala, kukhona ukuhluka okuphawulekayo kobukhulu besimila kanye nokubandakanyeka kwama-lymph node okulawula indlela yokwelapha.

Ezigulini eziningi, uhambo luqala ngokuxilongwa okuqinisekile okulandelwa uhlolo olubanzi lomaka webhayoloji. Lesi sinyathelo asisakhethwa; kuyindinganiso yokunakekela. Ukuhlolwa kwe-EGFR, ALK, kanye ne-PD-L1 expression kusiza izazi ze-oncologist ukuthi zinqume ukuthi isiguli singazuza yini ekwelashweni okuhlosiwe noma i-immunotherapy, ngaphambi noma ngemva kokuhlinzwa. Le ndlela eqhutshwa idatha iqinisekisa lokho isigaba esisodwa somdlavuza wamaphaphu ayiyona iphrothokholi enosayizi owodwa kodwa iwuhlelo oluklanyelwe ukukhulisa ukusinda nokunciphisa ukuphindeka.

Iqhaza Lokuhlinza Okuncane Kancane

Ukuhlinzwa kuseyinsika yenhloso yokwelapha ye-NSCLC yesigaba sokuqala. Kodwa-ke, amasu okuhlinza asetshenziswa ngo-2026 asukile kakhulu ku-thoracotomy yendabuko evulekile. Izinga lamanje lokunakekelwa lincoma kakhulu izindlela ezingavamisile ezigulini ngaphandle kokuphikisana kwe-anatomical.

• Ukuhlinzwa Kwethoracoscopic Okusizwa Ngevidiyo (i-VATS): Le nqubo isebenzisa izimbobo ezincane kanye nekhamera ukuze isuse isimila. Kuhlotshaniswa nobuhlungu obuncane, ukuhlala isikhathi esifushane esibhedlela, kanye nezikhathi zokululama ngokushesha uma kuqhathaniswa nokuhlinzwa okuvulekile.
• Ukuhlinzwa okusizwa ngerobhothi: Itholakala ngokwandayo ezibhedlela zaseShayina ezisezingeni eliphezulu, amasistimu wamarobhothi ahlinzeka odokotela abahlinzayo ngobuchule obuthuthukisiwe kanye nokubonwa kwe-3D. Lokhu kuvumela ukuhlukaniswa kwama-lymph node okunembile kanye nokukhishwa okuyinkimbinkimbi obekunzima ngaphambili ukwenza kancane kancane.

Ukukhetha phakathi kwe-VATS nokuhlinzwa kwerobhothi kuvame ukuncika kulwazi lukadokotela ohlinzayo kanye nezici ezithile zesimila. Kumathumba aseduze namasentimitha angu-3 ane-negative lymph nodes ye-mediastinal, lezi zindlela ezihlasela kancane ziwumugqa wokuqala okhethwayo wokuzivikela. Inhloso kuhlale kungu-R0 resection, okusho ukususwa ngokuphelele kwesimila ngamamajini acacile.

I-Stereotactic Ablative Radiotherapy Njengenye Indlela

Akusona sonke isiguli esinomdlavuza wamaphaphu wesigaba sokuqala esidinga ukuhlinzwa. Izinto ezifana nokuguga, ukungasebenzi kahle kwamaphaphu, noma ukugula okubalulekile kungenza izingozi zokuhlinzwa zingamukeleki. Kulaba bantu, I-stereotactic ablative radiotherapy (SABR), eyaziwa nangokuthi i-SBRT, ivele njengenye indlela esebenza kahle kakhulu.

I-SABR iletha imithamo ephezulu yemisebe ngokunemba okwedlulele esimila ngenkathi isindisa izicubu ezinempilo ezizungezile. Idatha yakamuva iphakamisa ukuthi ezigulini ezisesigabeni sokuqala ezingasebenzi ngokwezokwelapha, i-SABR inganikeza amazinga okulawula wendawo afana nokuhlinzwa. Ngo-2026, imihlahlandlela yomtholampilo isekela inqubo yokwenza izinqumo okwabelwana ngazo lapho iziguli zaziswa ukuthi i-SABR iyindlela yokwelapha ephumelelayo uma ukuhlinzwa kungenzeki.

Ngaphezu kwalokho, kwezinye iziguli ezikwazi ukusebenza ngobuchwepheshe kodwa ezikhetha ukugwema ukuhlinzwa, i-SABR iya ngokuya kuxoxwa ngayo njengenye indlela elandela ukwelulekwa okuphelele. Ubuchwepheshe obusekela i-SABR buye baba ngcono, okuvumela ukuphathwa okungcono kokunyakaza kanye nokudweba umthamo, okuthuthukisa ukusebenza kahle kwayo ngokumelene nezimila zamaphaphu ezihambayo.

I-Perioperative Immunotherapy: Ukuphumelela Okukhulu ngo-2026

Enye yentuthuko ebaluleke kakhulu ku isigaba esisodwa somdlavuza wamaphaphu eminyakeni yamuva nje ukuhlanganiswa kwe-immunotherapy endaweni ye-perioperative. Ngokomlando, i-chemotherapy yayiwukwelashwa okujwayelekile kwe-adjuvant ngemva kokuhlinzwa ezigulini ezisengozini enkulu. Kodwa-ke, i-paradigm isishintshile ngokwethulwa kwama-immune checkpoint inhibitors njenge-pembrolizumab.

Ucwaningo lwe-KEYNOTE-671 lube semqoka ekubumbeni kabusha izimiso zokwelapha. Lesi sivivinyo esiyingqopha-mlando sabonisa ukuthi ukuphatha i-pembrolizumab ngaphambi kokuhlinzwa (neoadjuvant) nangemuva kokuhlinzwa (i-adjuvant), kuhlanganiswe nokwelashwa ngamakhemikhali, kuthuthukisa kakhulu ukusinda ngaphandle kwemicimbi. Ngo-2026, idatha yesikhathi eside evela kulolu cwaningo, enezinyanga ezingaphezu kwe-60 yokulandelela, iqinise indima yale ndlela.

Izinzuzo Kungakhathaliseki Ukusabela Okuphelele Kwe-Pathological

Okutholakele okubalulekile ekuhlaziyweni kwakamuva kocwaningo lwe-KEYNOTE-671 ukuthi iziguli ziyazuza ku-perioperative immunotherapy kungakhathaliseki ukuthi zithola impendulo ephelele ye-pathological (pCR). I-pCR isho ukungabikho kwamaseli wesimila asebenzayo esibonelweni sokuhlinzwa ngemva kokwelashwa kwe-neoadjuvant.

• pCR Population: Iziguli ezithole i-pCR zibonise ukwehla okumangazayo engcupheni yokuqhubeka kwesifo noma ukufa, ngenani lengozi elivuna kakhulu iqembu le-immunotherapy.
• I-Non-pCR Population: Okubalulekile, ngisho neziguli ezingazange zizuze i-pCR zisathola inzuzo enkulu yokusinda. Isilinganiso sezingozi zaleli qembu sabonisa ukwehla okunengqondo kwengozi uma kuqhathaniswa nalabo abathola ukwelashwa ngamakhemikhali kuphela.

Le datha iphakamisa ukuthi ukusebenza kwamasosha omzimba kunikeza umphumela wokuvikela oqinile owedlulela ngale kokushwabana kwesimila ngokushesha. Kusikisela ukuthi izimpendulo ze-pathological "ezijulile" zihlotshaniswa nemiphumela engcono, kodwa noma yiliphi izinga lokubandakanya amasosha omzimba linenzuzo. Ngakho-ke, ochwepheshe be-oncologists e-China nasemhlabeni jikelele manje sebehlola njalo iziguli ezifanelekile zesigaba II kanye ne-IIA ngale ndlela ehlanganisiwe yendlela yokwenza.

Ukunwebela Ezigabeni Zangaphambili

Nakuba ukuphumelela kokuqala kubonakala esigabeni sesi-II nese-III, impumelelo ye-perioperative immunotherapy ikhuthaza uphenyo mayelana nokusetshenziswa kwayo ezigulini ezisengozini enkulu yesigaba I. Nakuba isifo sesigaba se-IA esijwayelekile ngokuvamile zelashwa ngokuhlinzwa kuphela, amathumba esiteji esikhulu se-IB noma lawo anezici eziyingozi kakhulu aya ngokuya ecatshangelwa amasu e-neoadjuvant ezivivinyweni zomtholampilo nasezikhungweni ezikhethekile.

Umqondo uwukwelapha isifo se-micrometastatic kusenesikhathi, ngaphambi kokuba isimila sikhishwe, ngaleyo ndlela kuncishiswe ithuba lokuphindeka. Lesi simo esisebenzayo simele uguquko olubalulekile endleleni esiwubheka ngayo umdlavuza wamaphaphu osesigabeni sokuqala—hhayi nje njengenkinga yendawo okufanele inqanyulwe, kodwa njengesifo esiwuhlelo esidinga ukulawulwa okuhlelekile kwasekuqaleni.

Izibhedlela Ezihamba Phambili ZaseChina Zokunakekelwa Komdlavuza Wamaphaphu

Lapho ufuna isigaba esisodwa somdlavuza wamaphaphu e-China, iziguli ziyakwazi ukufinyelela kwezinye zezikhungo zezokwelapha ezithuthuke kakhulu emhlabeni. Izwe lenze amagxathu abalulekile ekulinganiseni ukunakekelwa kanye nokwamukela imihlahlandlela yamazwe ngamazwe ngenkathi lisebenzisa umthamo walo omkhulu wesiguli ukuze liqhubekisele phambili ucwaningo nokusungula izinto ezintsha.

Ukukhetha isibhedlela esifanele kubalulekile. Izikhungo eziphezulu zibonakala ngamaqembu azo ahlukahlukene (i-MDT), okuhlanganisa odokotela abahlinza isifuba, izazi zezokwelapha, izazi ze-radiation oncologists, izazi ze-radiologist, kanye nezazi zezifo ezisebenza ndawonye ukwenza uhlelo olungcono kakhulu lwesiguli ngasinye. Lezi zikhungo futhi zihamba phambili ekusebenziseni uhlelo lwe-AJCC 9th edition kanye nokwenza ukuhlolwa kwamangqamuzana okudingekile.

I-Tianjin Medical University Cancer Institute kanye nesibhedlela

Itholakala eTianjin, lesi sikhungo singumholi kazwelonke ku-oncology. Ngaphansi kokuqondisa kochwepheshe abafana noSolwazi You Jian, isibhedlela sibe nesandla ekuhumusheni nasekusebenziseni idatha evela ezivivinyweni ezinkulu zamazwe ngamazwe njenge-KEYNOTE-671. Umnyango wabo wokuhlinza i-thoracic waziwa ngezinqubo zokunciphisa umthamo omncane kakhulu kanye nezinqubo zokunakekelwa eziqinile ze-perioperative.

Isibhedlela sigcizelela ukubaluleka kokuhlolwa kwe-pathological kanye nephrofayili yamangqamuzana. Basungule ukugeleza komsebenzi okuqinile ukuze baqinisekise ukuthi sonke isiguli se-NSCLC esenziwe kabusha siyahlolwa ngezinzuzo ezingaba khona ze-immunotherapy. Iminikelo yabo yocwaningo isiza ukuchaza izinga lokunakekelwa hhayi e-China kuphela, kodwa kulo lonke elase-Asia.

Isibhedlela Sabantu Sesifundazwe saseZhejiang kanye Nesibhedlela Somdlavuza saseZhejiang

E-Hangzhou, isibhedlela somdlavuza iZhejiang, esiholwa ochwepheshe abafana noSolwazi Xu Yujin, singesinye esinamandla ekwelapheni umdlavuza wamaphaphu. Lesi sibhedlela saziwa ngokuhlanganisa ubuchwepheshe obusezingeni eliphezulu ekuxilongeni nasekwelashweni. Babamba iqhaza ngenkuthalo ezivivinyweni zomtholampilo zomhlaba wonke, banikeze iziguli ukufinyelela emithi yokwelapha emisha ngaphambi kokuba itholakale kabanzi.

Indlela yabo yokuya esigabeni sokuqala somdlavuza wamaphaphu ibandakanya ukuhlelwa ngokucophelela kwangaphambi kokuhlinzwa, okuhlanganisa nesiteji esihlaselayo se-mediastinal lapho kudingeka. Basebenzisa amasu okucabanga athuthukile kanye nokuxilongwa okusizwa yi-AI ukuze bathole ukubandakanyeka okucashile kwe-nodal okungase kuphuthelwe kwenye indawo, baqinisekise ukuthi uhlelo lokwelapha luhambisana ngokuphelele nesigaba sesifo.

Isibhedlela Esisebenzisanayo Sokuqala sase-Sun Yat-sen University

Ngokusekelwe e-Guangzhou, lesi sibhedlela sinikeza ukunakekelwa okuphelele ngokugxila okuqinile kumasu okwelapha abantu ngabanye. USolwazi Cheng Chao nethimba lakhe bazinikele ekwandiseni ukulandelana kwezindlela zokwelapha. Banekhono ikakhulukazi ekulawuleni izimo eziyinkimbinkimbi lapho ukugula kungase kube nzima izindlela zokwelashwa ezijwayelekile.

Isikhungo sigcizelela kakhulu imfundo yesiguli kanye nokuthathwa kwezinqumo okwabelwana ngazo. Baqinisekisa ukuthi iziguli ziyawaqonda ama-nuances okuxilongwa kwazo, isizathu sokukhetha ukuhlinzwa uma kuqhathaniswa ne-SABR, kanye nezinzuzo ezingaba khona zokwengeza i-immunotherapy. Le modeli egxile esigulini ihambisana nokuthambekela komhlaba wonke ekunakekelweni kwezempilo okusekelwe entweni.

Izinqubo Zokuxilonga Nokunemba Kwesiteji

Isiteji esinembayo siyisisekelo sokusebenza ngempumelelo isigaba esisodwa somdlavuza wamaphaphu. Ukubhala kabi kungaholela ekwelashweni okunganele noma ubuthi obungadingekile. Ngo-2026, izibhedlela zaseChina zilandela imigomo eqinile yokuxilonga ukuze ziqinisekise ukunemba.

Ukwamukelwa kwe-AJCC 9th Edition

Ukushintshela kusistimu yesiteji ye-TNM ye-AJCC yesi-9 ilethe ukuhlukaniswa kwezigaba okuthe xaxa. Lesi sibuyekezo silungisa izincazelo zezigaba zosayizi wesimila kanye neziteshi ze-lymph node. Isibonelo, umehluko phakathi kwamathumba e-T1a, T1b, kanye ne-T1c manje ubaluleke kakhulu ekunqumeni izinga lokuhlinzwa kanye nesidingo sokwelashwa kwe-adjuvant.

Izibhedlela e-China zibuyekeze izinhlelo zazo zokubika ukuze zihambisane nalawa mazinga amasha. Lokhu kuqinisekisa ukungaguquguquki ekuxhumaneni phakathi kwabelaphi futhi kusiza ukubhaliswa okunembile ezivivinyweni zomtholampilo. Iphinde ivumele ukubikezela okubikezelwayo okungcono, ukusiza iziguli nodokotela babeke okulindelwe okungokoqobo.

Ukuhlolwa Okuphoqelekile Kwe-Molecular Biomarker

Sezadlula izinsuku lapho ukuhlolwa kwe-biomarker bekugcinelwe isifo esisezingeni eliphezulu. Iziqondiso zamanje zigunyaza ukuthi zonke iziguli ezine-NSCLC ekhishwa kabusha zihlolwe abashayeli ababalulekile. Lokhu kufaka phakathi ukuguqulwa kwe-EGFR, ukuhlela kabusha kwe-ALK, namaleveli wokusho we-PD-L1.

• I-EGFR ne-ALK: Ukuhlonza lezi zinguquko kubalulekile ngoba kungase kube nomthelela ekukhethweni kokwelashwa kwe-adjuvant. Iziguli ezinokuguqulwa kwe-EGFR, isibonelo, zingazuza ku-tyrosine kinase inhibitors (TKIs) ehlosiwe ngemuva kokuhlinzwa.
• I-PD-L1: Izinga lesisho se-PD-L1 lisiza ukubikezela amathuba okuphendula ku-immunotherapy. Nakuba i-perioperative pembrolizumab ivunyiwe kungakhathaliseki isimo se-PD-L1 kwezinye izimo, ukwazi izinsiza zesimo ekuhlaziyweni kwenzuzo engozini.

Lokhu kuhlola okuphelele manje sekuyinjwayelo ezibhedlela eziphezulu zaseChina. Isikhathi sokushintsha imiphumela sehlile ngenxa yengqalasizinda yelabhorethri ethuthukisiwe, evumela ukwelashwa ukuthi kuqale ngaphandle kokubambezeleka okungadingekile.

Ukuhlasela kwe-Medistinal Staging

Ukucabanga kukodwa kwesinye isikhathi akwanele ukukhipha i-lymph node metastasis. Ezigulini eziningi zesigaba somtholampilo I no-II, ikakhulukazi lezo ezinamathumba amaphakathi noma ama-node asolisayo kumaskeni we-CT/PET, ukuhlasela kwe-mediastinal kunconywa ngaphambi kokuhlinzwa.

Amasu afana ne-Endobronchial Ultrasound (EBUS) kanye ne-Endoscopic Ultrasound (EUS) asetshenziswa kabanzi. Lezi zinqubo ezihlasela kancane zivumela i-biopsy yesikhathi sangempela yama-lymph nodes e-mediastinal. Uma isifo se-N2 siqinisekiswa, uhlelo lokwelapha luyashintsha lusuka ekuhlinzweni kwangaphambili luye ekwelashweni kwe-neoadjuvant, ngokuyisisekelo lushintsha umkhondo wesiguli.

Ukuhlaziywa Kwezindleko Nokufakwa Komshuwalense e-China

Ukuqonda isici sezezimali se isigaba esisodwa somdlavuza wamaphaphu kubalulekile ezigulini ezihlela ukunakekelwa kwazo e-China. Izindleko zingahluka kakhulu kuye ngezinga lesibhedlela, ukwelashwa okuqondile okudingekayo, kanye nesimo somshuwalense wesiguli.

Ukwehlukaniswa kwezindleko zokwelashwa

Isamba sezindleko zokwelashwa sihlanganisa izingxenye ezimbalwa: umsebenzi wokuxilonga, ukuhlinzwa noma ngemisebe, i-pathology, ukuhlolwa kwamangqamuzana, nanoma yiziphi izindlela zokwelapha ezihlelekile.

• Ukuxilongwa kanye nokufakelwa: Ukubonisana kwasekuqaleni, ama-CT scan, i-PET-CT, ne-MRI yobuchopho kungasukela ezinkulungwaneni ezimbalwa kuye ngaphezu kwezinkulungwane eziyishumi ze-RMB. Izinqubo zesiteji ezihlaselayo ezifana ne-EBUS zengeza kulezi zindleko.
• Ukuhlinzwa: Ukuhlinzwa okuhlaselayo okuncane (i-VATS noma i-robotic) ngokuvamile kubiza ngaphezu kokuhlinzwa okuvulekile ngenxa yezisetshenziswa namakhono ayisipesheli adingekayo. Ukuhlinzwa kwerobhothi, ikakhulukazi, kungabiza kakhulu, ngokuvamile kudlule i-50,000 kuya ku-80,000 RMB kuye ngobunkimbinkimbi.
• I-Radiotherapy: Izifundo ze-SABR wutshalomali olukhulu, okungenzeka lubize phakathi kuka-30,000 no-60,000 RMB, okubonisa ubuchwepheshe obuthuthukisiwe kanye nokuhlela okuhilelekile.
• Ukwelashwa Kwesistimu: Izindleko zokwelashwa ngamakhemikhali zilinganiselwe, ikakhulukazi ngezinketho ezijwayelekile. Kodwa-ke, ama-immunotherapy anjenge-pembrolizumab angabiza. Nakuba amanani ehlile ngenxa yezingxoxo zikazwelonke, inkambo egcwele yokwelashwa kwe-perioperative isengaba amashumi ezinkulungwane zama-RMB.

Izinqubomgomo Zokukhokhelwa Komshwalense

Uhlelo lomshwalense wezokwelapha oluyisisekelo lwaseChina luhlanganisa ingxenye ebalulekile yokwelashwa okujwayelekile. Ukuhlinzwa, ukwelashwa ngamakhemikhali okuvamile, kanye ne-radiotherapy eyisisekelo kuvame ukumbozwa kahle. Kodwa-ke, ukufakwa kwezindlela zokwelapha ezintsha ezifana ne-immunotherapy nokuhlinzwa kwerobhothi kuyehluka ngokwesifunda nohlelo oluthile lomshwalense.

Eminyakeni yamuva, imithi eminingi emisha, kuhlanganise nemithi yokwelapha eyisihluthulelo, iye yafakwa ohlwini Lwezidakamizwa Lokubuyisela Imali Kazwelonke (NRDL). Lokhu kunciphise kakhulu izindleko eziphuma ephaketheni ezigulini. Isibonelo, i-pembrolizumab namanye ama-PD-1 inhibitor manje abuyiselwa kancane ezinkomba ezithile, okuwenza afinyeleleke kubantu abaningi.

Iziguli zelulekwa ukuthi zithintane nehhovisi lomshwalense wesibhedlela kusenesikhathi. Ezinye izibhedlela ziphinde zinikeze ubambiswano lomshwalense wezohwebo noma izinhlelo zosizo ukusiza ukuvala igebe lokwelashwa okubizayo okungambozwanga ngokugcwele umshwalense oyisisekelo.

Isinyathelo Ngesinyathelo Umhlahlandlela Wokuzula Ukwelashwa e-China

Ezigulini zamazwe ngamazwe noma ezifuywayo ezifuna ukunakekelwa, ukuzulazula ohlelweni lokunakekelwa kwezempilo kungase kube nzima. Indlela ehlelekile iqinisekisa ukuthi azikho izinyathelo ezibucayi ezigejwayo nokuthi isiguli sithola okungcono kakhulu isigaba esisodwa somdlavuza wamaphaphu.

• Isinyathelo 1: Umbono Wesibili kanye Nokubuyekezwa Kwerekhodi: Ngaphambi kokuzibophezela ohlelweni lokwelashwa, thola umbono wesibili. Izibhedlela eziningi eziphezulu zinikeza izinsiza zokubonisana ezikude lapho ochwepheshe bebuyekeza imibiko ekhona yezithombe kanye ne-pathology. Lokhu kuqinisekisa ukuxilongwa kanye nokunemba kwesiteji.
• Isinyathelo sesi-2: Ukuhlola Okuphelele Kwe-Biomarker: Qinisekisa ukuthi amasampula ezicubu athunyelwa ukuze agcwaliswe ngokugcwele ngamamolekyuli. Uma i-biopsy yokuqala inganele, kungase kudingeke ukuthi kuphindwe kwenziwe i-biopsy. Ungaqhubeki nokwelashwa okuqondile ngaphandle kwale miphumela.
• Isinyathelo sesi-3: Ingxoxo Yethimba Lezinhlaka Ezihlukahlukene (MDT): Cela umhlangano we-MDT. Lokhu kuqinisekisa ukuthi odokotela abahlinzayo, izazi ze-oncologists, kanye nezazi ze-radioologists zivumelana ngokuhlanganyela ngokulandelana okuhle kakhulu kwezindlela zokwelapha. Buza ngokuqondile mayelana nokufaneleka kwe-perioperative immunotherapy.
• Isinyathelo sesi-4: Ukuhlelwa Kokuhlinzwa noma Kwemisebe: Uma kukhethwa ukuhlinzwa, xoxani ngendlela (VATS vs. Robotic). Uma i-SABR ikhethiwe, qinisekisa ulwazi lwesikhungo kanye nobuchwepheshe. Qinisekisa umugqa wesikhathi wokuqaliswa kokwelashwa.
• Isinyathelo sesi-5: Ukubhekwa ngemuva kokwelashwa: Misa uhlelo lokulandelela olucacile. Ukutholwa kusenesikhathi kokuphinda kubalulekile. Lokhu ngokuvamile kuhilela ama-CT scan avamile kanye nokuhlolwa komtholampilo okungenani iminyaka emihlanu.

Ukulandela lezi zinyathelo kunikeza iziguli amandla okubamba iqhaza elibonakalayo ekunakekeleni kwazo. Iphinde iqinisekise ukuhambisana nemihlahlandlela yakamuva ka-2026, ikhulise amathuba okwelapha.

Ukuhlaziywa Okuqhathaniswayo Kwezindlela Zokwelapha

Ukusiza iziguli kanye nemindeni ukuthi baqonde izinketho zabo, ithebula elilandelayo liqhathanisa izindlela zokwelapha ezitholakala esigabeni sokuqala somdlavuza wamaphaphu ngo-2026.

Lesi siqhathaniso sigqamisa ukuthi nakuba ukuhlinzwa kuseyindlela eyinhloko yokwelapha, umongo okulethwa kuwo ushintshile. Ukwengezwa kokwelashwa kwesistimu kanye nokuba khona kwezinye izindlela zokukhishwa kwemisebe yezinga eliphezulu kunikeza inethi yokuphepha yezidingo zesiguli ezihlukahlukene.

Amathrendi Azayo kanye Nobuchwepheshe Abasafufusa

Uma ubheka ngale kuka-2026, inkambu yokwelashwa komdlavuza wamaphaphu iyaqhubeka nokuqamba izinto ezintsha. Amathrendi amaningana asafufusa alungele ukuqhubeka nokucwengwa isigaba esisodwa somdlavuza wamaphaphu futhi uthuthukise imiphumela.

I-Artificial Intelligence ekuxilongweni

Ama-algorithms e-AI aqala ukuba yingxenye yokugeleza komsebenzi wokuxilonga. Lawa mathuluzi angakwazi ukuhlaziya ama-CT scan ngokunemba okungaphezu komuntu, athole amaqhuqhuva acashile futhi abonise ama-lymph node amehlo abantu angase awageje. E-China, “i-China Protocol” yokuhlolwa komdlavuza wamaphaphu isebenzisa i-AI ukuze ithuthukise amazinga okutholwa kusenesikhathi, iphushe ingxenye yesigaba sokuhlonza isifo sibe phezulu.

I-AI iphinde isize ekuhleleni ukwelashwa ngokubikezela ukuthi yiziphi iziguli okungenzeka kakhulu ziphendule ekwelapheni okuthile. Leli khono lokubikezela lisondeza umuthi ekwenziweni komuntu kwangempela, kunciphisa ukuchazwa kwesilingo namaphutha.

I-Liquid Biopsy yokuqapha

Ukuhlolwa kwe-Curculating tumor DNA (ctDNA), noma i-liquid biopsy, kuthola amandla njengethuluzi lokuqapha impendulo yokwelashwa kanye nokuthola isifo esincane esiyinsalela (MRD). Ngemuva kokuhlinzwa, ukuhlolwa kwe-ctDNA enhle kungase kubonise amangqamuzana omdlavuza asele, okubangela ukungenelela kwangaphambi kwesikhathi ngokwelashwa kwe-adjuvant.

Le ndlela engahlanyisi inikeza umbono oguquguqukayo wesimo sesifo, okuvumela odokotela ukuthi balungise izinhlelo zokwelapha ngesikhathi sangempela. Njengoba ubuchwepheshe buzwela kakhulu futhi bufinyeleleka kalula, kulindeleke ukuthi bube yingxenye evamile yokugada ngemva kokuhlinzwa.

Gxila Ekusindeni Nekhwalithi Yempilo

Njengoba amazinga okusinda ethuthuka, kugxilwa kuzinga lempilo yabasindile. Izinhlelo ezikhuluma ngokulondolozwa kokuzala, ukuqapha impilo yenhliziyo, nokusekelwa kwengqondo ziyahlanganiswa ezinhlelweni zokwelashwa. Ziqaphela ukuthi umdlavuza usuyisimo esingalawuleki esilawulekayo kwabaningi, izibhedlela zisebenzisa indlela ephelele yokunakekela.

Lolu shintsho luyavuma ukuthi ukwelapha lesi sifo kuyingxenye yomgomo; ukusiza iziguli zibuyele ekuphileni okwanelisayo kubaluleke ngokufanayo. Izinsizakalo zokunakekela ezisekelayo ziyakhula ukuze zihlangabezane nezidingo "zesizukulwane sesandwich" seziguli ezilinganisa ukwelashwa nomsebenzi kanye nezibopho zomndeni.

Imibuzo Evame Ukubuzwa Mayelana Nesigaba Sokuqala Ukwelashwa Umdlavuza Wamaphaphu

Ingabe umdlavuza wamaphaphu wesigaba sokuqala uyelapheka?

Yebo, isigaba sokuqala somdlavuza wamaphaphu siyelapheka kakhulu. Ngokwelashwa okufanele, njengokuhlinzwa noma i-SABR, izinga lokusinda leminyaka emihlanu lesifo sesiteji IA lingadlula ama-90%. Okubalulekile ukutholwa kusenesikhathi kanye nokubambelela ezimisweni zokwelashwa ezisezingeni.

Kuthatha isikhathi esingakanani ukwelashwa?

Ubude besikhathi buhluka ngokwendlela. Ukuhlinzwa ngokuvamile kubandakanya ukuhlala esibhedlela izinsuku ezi-3 kuye kweziyi-7, ukululama okuphelele kuthatha amaviki ambalwa kuya ezinyangeni. Uma i-perioperative immunotherapy yengezwa, yonke inkambo yokwelashwa, okuhlanganisa nezigaba zangaphambi kokuhlinzwa, zingathatha izinyanga eziyisi-6 kuya kweziyi-12. I-SABR ivamise ukuqedwa ngeseshini e-1 ukuya kwezi-5 esikhathini esingangesonto noma amabili.

Ngingathola i-immunotherapy yomdlavuza wamaphaphu wesigaba sokuqala?

Njengamanje, i-perioperative immunotherapy indinganiso ye-NSCLC yesigaba II kanye ne-III. Ngesifo sesigaba I esimsulwa, ngokuvamile asiboniswa ngaphandle kwalapho kunezici ezinobungozi obuphezulu noma ukubhaliswa ocwaningweni lomtholampilo. Kodwa-ke, imihlahlandlela iguquka ngokushesha, ngakho-ke ukuxoxa ngendaba yakho ethile nodokotela oyi-oncologist kubalulekile.

Iyini imiphumela emibi yokwelashwa?

Ukuhlinzwa kunezingozi ezifana nokutheleleka, ukopha, nobuhlungu, nakuba izindlela ezihlasela kancane zinciphisa lokhu. I-Immunotherapy ingabangela izenzakalo ezimbi ezihlobene nokuzivikela komzimba ezithinta amaphaphu, isikhumba, noma amathumbu. I-SABR ingabangela ukukhathala noma ukuvuvukala kwendawo. Imiphumela emibi eminingi iyalawuleka ngokugadwa okufanele kwezokwelapha.

Isiphetho: Ukuthatha Isinyathelo Ngemiphumela Engcono

Unyaka wezi-2026 umaka isikhathi sethuba elingakaze libonwe ezigulini ezine isigaba esisodwa somdlavuza wamaphaphu. Intuthuko kumasu okuhlinza, ukuhlanganiswa kwe-perioperative immunotherapy, kanye nokunemba kokuxilongwa kwesimanje kuye kwaguqula ukubikezelwa komdlavuza wamaphaphu wesigaba sokuqala. E-China, izibhedlela ezisezingeni lomhlaba zihamba phambili, zinikeza ukunakekelwa okuyizimbangi ezihamba phambili emhlabeni.

Impumelelo ekwelapheni umdlavuza wamaphaphu incike ekuhlanganisweni kwesenzo esifike ngesikhathi, isiteji esinembile, kanye nokufinyelela kochwepheshe bemikhakha eminingi. Iziguli zikhuthazwa ukuthi zifune ukunakekelwa ezikhungweni ezikhethekile lapho iziqondiso zakamuva zilandelwa ngokuqinile. Kungakhathaliseki ukuthi ngokuhlinzwa okuhlaselayo kancane, ngemisebe ethuthukisiwe, noma izinhlanganisela zokwelashwa kwe-systemic, umgomo ucacile: ukwelapha kanye nokubuyela kukhwalithi ephezulu yempilo.

Ukuzulazula kulolu hambo kudinga izinqumo ezinolwazi. Ngokuqonda izinketho ezitholakalayo, ukubaluleka kokuhlolwa kwe-biomarker, kanye nezinzuzo ezingaba khona zezindlela zokwelapha ezintsha, iziguli zingamela ukunakekelwa okungcono kakhulu. Ikusasa lokwelashwa komdlavuza wamaphaphu liqhakazile, liqhutshwa isayensi nokuzibophezela ekunakekelweni kwenani okugxiliswe esigulini.